K-numberK250809
Device nameStellar M22
ApplicantLumenis Be, Ltd.
Product codeGEX
Device classClass II
Decision dateApr 16, 2025
DecisionSubstantially Equivalent
Regulation878.4810
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Stellar M22 is a multi-application laser and intense pulsed light (IPL) system for aesthetic dermatology procedures. It offers four interchangeable handpieces (IPL, Multi-Spot Nd:YAG, ResurFX, and Q-Switched Nd:YAG) to treat various skin conditions including benign lesions, vascular lesions, unwanted hair, acne, wrinkles, tattoos, and pigmented lesions across skin types I-V.

Technological characteristics

The subject device has identical wavelengths (400–1200 nm), maximum energy (up to 40 or 70 mJ per microbeam), handpiece configuration, and accessories as the predicate K193500. The primary modification is the addition of new hardware for secure cloud-based transmission of technical data to enable remote service and problem-solving capabilities, while maintaining the same clinical functionality and treatment specifications.

Test standards cited

Risk analysis per ISO 14971; electrical, laser and electromagnetic compatibility safety testing per IEC 60601-1 and IEC 60601-1-2; software verification and validation per IEC 62304 and FDA Guidance on Software Validation (January 2002); and system testing for performance, functionality, and communication.

Substantial equivalence argument

The modifications introduced are hardware-only additions for remote service infrastructure and do not alter the device's intended use, clinical indications, wavelengths, energy outputs, or treatment handpieces. Because the subject device performs identically to the predicate (K193500) in all clinically relevant parameters and the added cloud connectivity hardware does not change safety or effectiveness profiles, the subject device is substantially equivalent. No new clinical validation was required because the predicate's clinical validation directly applies to the subject device.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →